Prevalence and causes of blindness and vision impairment magnitude, Temporal Trends, and Projections in South and Central Asia
File(s)author manuscript.pdf (513.7 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Background: To assess prevalence and causes of vision loss in Central 68 and South Asia.
Methods: A systematic review of medical literature assessed the prevalence of blindness (presenting visual acuity<3/60 in the better eye), moderate and severe vision impairment (MSVI; presenting visual acuity <6/18 but ≥3/60) and mild vision impairment (MVI; presenting visual acuity <6/12 and ≥6/18) in Central and South Asia for 1990, 2010, 2015, and 2020.
Results: In Central and South Asia combined, age-standardized prevalences of blindness, MSVI and MVI in 2015 were for men and women 2.80% (80%uncertainty interval (UI):1.14-4.91) and 3.47% (80%UI:1.45-5.99),16.75% (80%UI:5.60-30.84) and 20.06% (80%UI:7.15-36.12), 11.49% (80%UI:3.43-21.44) and 12.77% (80%UI:4.04-23.48), respectively, with a significant decrease in the study period for both gender. In South Asia in 2015, 11.76 million individuals (32.65% of the global blindness figure) were blind and 61.19 million individuals (28.3% of the global total) had MSVI. From 1990 to 2015, cataract (accounting for 36.58% of all cases with blindness in 2015) was the most common cause of blindness, followed by undercorrected refractive error (36.43%), glaucoma (5.81%), age-related macular degeneration (2.44%), corneal diseases (2.43%), diabetic retinopathy (0.16%) and trachoma (0.04%). For MSVI in South Asia 2015, most common causes were under corrected refractive error (accounting for 66.39% of all cases with MSVI), followed by cataract (23.62%), age related macular degeneration (1.31%) and glaucoma (1.09%).
Conclusions: One third of the global blind resided in South Asia in 2015, although the age-standardized prevalence of blindness and MSVI decreased significantly between 1990 and 2015.
Methods: A systematic review of medical literature assessed the prevalence of blindness (presenting visual acuity<3/60 in the better eye), moderate and severe vision impairment (MSVI; presenting visual acuity <6/18 but ≥3/60) and mild vision impairment (MVI; presenting visual acuity <6/12 and ≥6/18) in Central and South Asia for 1990, 2010, 2015, and 2020.
Results: In Central and South Asia combined, age-standardized prevalences of blindness, MSVI and MVI in 2015 were for men and women 2.80% (80%uncertainty interval (UI):1.14-4.91) and 3.47% (80%UI:1.45-5.99),16.75% (80%UI:5.60-30.84) and 20.06% (80%UI:7.15-36.12), 11.49% (80%UI:3.43-21.44) and 12.77% (80%UI:4.04-23.48), respectively, with a significant decrease in the study period for both gender. In South Asia in 2015, 11.76 million individuals (32.65% of the global blindness figure) were blind and 61.19 million individuals (28.3% of the global total) had MSVI. From 1990 to 2015, cataract (accounting for 36.58% of all cases with blindness in 2015) was the most common cause of blindness, followed by undercorrected refractive error (36.43%), glaucoma (5.81%), age-related macular degeneration (2.44%), corneal diseases (2.43%), diabetic retinopathy (0.16%) and trachoma (0.04%). For MSVI in South Asia 2015, most common causes were under corrected refractive error (accounting for 66.39% of all cases with MSVI), followed by cataract (23.62%), age related macular degeneration (1.31%) and glaucoma (1.09%).
Conclusions: One third of the global blind resided in South Asia in 2015, although the age-standardized prevalence of blindness and MSVI decreased significantly between 1990 and 2015.
Date Issued
2019-06-21
Date Acceptance
2018-09-23
Citation
British Journal of Ophthalmology, 2019, 103 (7), pp.871-877
ISSN
0007-1161
Publisher
BMJ Publishing Group
Start Page
871
End Page
877
Journal / Book Title
British Journal of Ophthalmology
Volume
103
Issue
7
Copyright Statement
© Author(s) (or their
employer(s)) 2019. No
commercial re-use. See rights
and permissions. Published
by BMJ.
employer(s)) 2019. No
commercial re-use. See rights
and permissions. Published
by BMJ.
Identifier
https://bjo.bmj.com/content/103/7/871
Subjects
Science & Technology
Life Sciences & Biomedicine
Ophthalmology
global burden of disease study
vision loss expert group
vision loss
blindness
vision impairment
refractive error
cataract
glaucoma
macular degeneration
epidemiology
GLOBAL PREVALENCE
VISUAL IMPAIRMENT
RANIBIZUMAB
POPULATION
WORLDWIDE
blindness
cataract
epidemiology
glaucoma
global burden of disease study
macular degeneration
refractive error
vision impairment
vision loss
vision loss expert group
Vision Loss Expert Group of the Global Burden of Disease Study
Ophthalmology & Optometry
1103 Clinical Sciences
1113 Opthalmology and Optometry
1117 Public Health and Health Services
Publication Status
Published
Date Publish Online
2018-11-08